Cancer Medicines: What Is Essential and Affordable in India?
Manju SengarAdam M FundytusWilma M HopmanConjeevaram S PrameshVenkatraman RadhakrishnanPrasanth GanesanAju MathewDorothy Chilambe LombeMatthew JalinkBishal GyawaliDario TrapaniFelipe Santa Rosa RoitbergElisabeth G E De VriesLorenzo MojaGerald W PragerRichard SullivanChristopher M BoothPublished in: JCO global oncology (2022)
Most high-priority cancer medicines identified by Indian oncologists are generic chemotherapy agents that provide substantial improvements in survival and are already included in WHO EML. Access to these treatments remains limited by major financial burdens experienced by patients. This is particularly acute within the private health system. Strategies are urgently needed to ensure that high-quality cancer care is affordable and accessible to all patients in India.